JPS60178361A - Diazo reagent for measuring bilirubin - Google Patents

Diazo reagent for measuring bilirubin

Info

Publication number
JPS60178361A
JPS60178361A JP3475984A JP3475984A JPS60178361A JP S60178361 A JPS60178361 A JP S60178361A JP 3475984 A JP3475984 A JP 3475984A JP 3475984 A JP3475984 A JP 3475984A JP S60178361 A JPS60178361 A JP S60178361A
Authority
JP
Japan
Prior art keywords
diazo
reagent
diazonium salt
bilirubin
diazo reagent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3475984A
Other languages
Japanese (ja)
Other versions
JPH0358468B2 (en
Inventor
Izumi Anai
穴井 泉
Masahiko Shimada
島田 正彦
Mayumi Yoneda
米田 真弓
Dotaro Fujimoto
藤本 導太郎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FUJIMOTO DAIAGUNOSUTEITSUKUSU KK
Original Assignee
FUJIMOTO DAIAGUNOSUTEITSUKUSU KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FUJIMOTO DAIAGUNOSUTEITSUKUSU KK filed Critical FUJIMOTO DAIAGUNOSUTEITSUKUSU KK
Priority to JP3475984A priority Critical patent/JPS60178361A/en
Publication of JPS60178361A publication Critical patent/JPS60178361A/en
Publication of JPH0358468B2 publication Critical patent/JPH0358468B2/ja
Granted legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/728Bilirubin; including biliverdin

Abstract

PURPOSE:To enhance the stability of a measuring reagent without changing the fundamental composition thereof and to eliminate preparation trouble at the time of use, by allowing alkali halide to coexist along with diazonium salt formed through the reaction of sodium nitrite and sulfanilic acid. CONSTITUTION:Alkali halide such as sodium chloride is allowed to coexist along with diazonium salt formed through the reaction of sulfanilic acid and sodium nitrite as a stabilizer in an amount 10-20 times that of diazonium salt in a mol ratio.

Description

【発明の詳細な説明】 本発明は、ビIJ )レビンの定量に使用される、安定
性にすぐれたジアゾ試薬に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a highly stable diazo reagent used for the determination of BiIJ) Levin.

血清中の総ビリルビンおよび直接ビリルビン量の測定は
、肝蔵糸の疾患の診断に欠くことのできない検査項目の
1・つである。ビリルビンの定量は、芳香族第一級アミ
ンのジアゾニウム塩を測定試薬とし、ビリルビンのジア
ゾカップリング反応により生成するアゾビリルビンを測
定することにより行なわれている。その代表的な方法は
、マロイーエヴ工りン( Malloy−F+vell
yn)法と、ミツチェμソン( Michaellso
n )法であり、前者はアゾビリルビンを測定し、後者
はアゾビリルビンをアルカリ性下で赤色から青色にシフ
トさせ、アルカリアゾビリルビンとして測定するもので
ある。このビリルビンの定量に使用されるジアゾニウム
塩は、スルファニル酸と亜硝酸ナトリウムとで用時調製
されている。ジアゾニウム塩の調製から、ビリルビンと
ジアゾニウム塩との反応によるアゾビリルビン(赤色、
特性吸収:580nm)の生成までを示せば次のとおり
である。
Measuring the total bilirubin and direct bilirubin levels in serum is one of the essential test items for diagnosing hepatic filament diseases. Quantification of bilirubin is carried out by using a diazonium salt of an aromatic primary amine as a measuring reagent and measuring azobilirubin produced by a diazo coupling reaction of bilirubin. The typical method is Malloy-F+vell.
yn) method and Michaellso
n) method, the former measures azobilirubin, and the latter shifts azobilirubin from red to blue under alkaline conditions and measures it as alkaline azobilirubin. The diazonium salt used for the determination of bilirubin is prepared immediately before use with sulfanilic acid and sodium nitrite. From the preparation of diazonium salts, azobilirubin (red color,
The process up to the generation of characteristic absorption: 580 nm is as follows.

SO2F SO2F ’ SO2F 〔ス/L/7アニp酸〕〔ジアゾニウム塩〕11 (X)011(シ00H 1ヒ゛ リ ル ビ ン 〕 1 (赤色) 0tJH 上記反応に使用されるジアゾニウム塩は極めて不安定で
、保存は不可能であるために、ビリルビン測定のつど調
製しなければならない。近時、この片時調製の不便を解
消する目的で、ジアゾ試薬のv定住を図った安定化ジア
ゾニウム塩法によるビリルビンの測定法も開発されてい
る。しかし、その方法においては、生成するアゾビIJ
 )レビンの種類が従来のそれと異なる点や、色合型ビ
l) )レビノの生体中でのネフ雑さのために、新生児
、透析患者、腎移植患者等の検体において従来法による
データとの差が指摘されはじめている。
SO2F SO2F 'SO2F [S/L/7 Anipic acid] [Diazonium salt] 11 (X)011 (S00H 1Hylylbin) 1 (Red) 0tJH The diazonium salt used in the above reaction is extremely unstable. Since it cannot be stored, it must be prepared each time bilirubin is measured.Recently, in order to eliminate the inconvenience of one-time preparation, a stabilized diazonium salt method has been developed to stabilize the diazo reagent. A method for measuring bilirubin has also been developed.However, in this method,
) Due to the difference in the type of Levin from that of conventional methods, and due to the roughness of Levin in vivo, there are differences in data from conventional methods in specimens of newborns, dialysis patients, kidney transplant patients, etc. is beginning to be pointed out.

本発明は上記に鑑みてなされたものであり、従来の測定
試薬の基本的組成を変化させることなくその安定14:
を高めて長時間の保存を可能にし、片時調製の煩られし
さを解消するとともに、従来と全く同様の311I定デ
ータが得られるようにしたビリルビン定量用ジアゾ試液
を提供する。
The present invention has been made in view of the above, and it is possible to stabilize the conventional measurement reagent without changing its basic composition.
To provide a diazo test solution for bilirubin determination, which can be stored for a long time by increasing the temperature, eliminates the trouble of one-time preparation, and provides 311I quantitative data exactly the same as conventional ones.

本発明のジアゾ試薬は、スルファニル酸と亜硝酸す1−
リウムとの反応により生成するジアゾニウム塩に、安定
化剤としてハロゲン化アルカリ金属塩を共存させてなる
ものである。
The diazo reagent of the present invention comprises sulfanilic acid and nitrous acid.
It is made by coexisting an alkali metal halide salt as a stabilizer with the diazonium salt produced by the reaction with lithium.

本発明のジアノ゛試薬は、ハロゲン化アルカリ金属塩の
存在により不安定なジアゾニウム塩中の一十 NヨN、 7;I:が安定化される。
In the diazonium reagent of the present invention, the unstable diazonium salts are stabilized by the presence of the alkali metal halide.

ハロゲン化アルカリ金属塩としては、特に塩化−J−)
 !J ウJ−(N:、+Cl) オ、1:び塩化/’
J 、u ラム(KO4)y)s好ましい。
As the alkali metal halide salt, especially chloride (J-)
! J UJ-(N:, +Cl) E, 1: Bichloride/'
J, u ram (KO4)y)s preferred.

ハロゲン化アルカリ金属塩の共存量はモ/I/数でジア
ゾニウム塩の10〜20倍量であればよい。
The coexisting amount of the alkali metal halide salt may be 10 to 20 times the amount of the diazonium salt in terms of mo/I/number.

本発明のジアゾ試薬は、ヌルファニル酸、亜硝酸すトリ
ムウおよびハロゲン化アルカリ金属塩をモル比で1:2
〜3:10〜20の割合で調合することにより製辿され
る。その他の製造条件に別設の制限はなく、通常のil
l、l製条件をその寸!−通用すればよい。例えば、精
製水に安定化剤として塩化すトリウム90〜1205J
/l、ヌルファニル酸4−6g/lおよび11°禁塩酸
6〜8ml/IJを溶解した試液C以下、[ジアゾ試液
Δ」)と、精製水に亜硝酸す1−リウム6〜8g/4を
溶解した試液(す1、「ジアゾ試液T−3j)とを適当
な割合で混合することにより調製される。
The diazo reagent of the present invention comprises nulfanilic acid, nitrite, and alkali metal halide in a molar ratio of 1:2.
It is manufactured by blending at a ratio of ~3:10-20. There are no separate restrictions on other manufacturing conditions, and normal IL
l, l manufacturing conditions at that size! -It's fine as long as it's valid. For example, 90-1205J of thorium chloride as a stabilizer in purified water.
/l, 4-6 g/l of nurphanilic acid and 6-8 ml/IJ of 11° hydrochloric acid dissolved in test solution C (hereinafter referred to as "diazo test solution Δ"), and 6-8 g/4 of 1-lium nitrite in purified water. It is prepared by mixing the dissolved test solution (S1, Diazo Test Solution T-3j) in an appropriate ratio.

次に、本発明のジアゾ試薬の調製、および該試薬による
ビIJ )レビン定量について実施例により具体的に説
明する。
Next, the preparation of the diazo reagent of the present invention and the quantification of BiIJ) Levin using the reagent will be specifically explained with reference to Examples.

実施例1 〔(〕 ジアゾ試薬 下記の緩衝液、ジアゾ試液ΔおよびBを準備する。Example 1 [(] Diazo reagent Prepare the following buffer solution and diazo test solutions Δ and B.

緩衝液 安息香酸すトリウム 569 無水カフエイン 879 酢酸す1−リウム 94g ブリッジ−35709 精製水 1e ジアゾ試腋A 塩化す1−リウム 11.7fl スルフアニル酸 0.52g 濃塩酸 0.72 ml 精製水 100m(! ジアゾ試東B 亜硝酸ナトリウム 076g fi’j ”−Lす水 100m1! 〔■〕ビリルビン量の4111定 血Wi 20 tillに緩衝液を2.5 me加え、
580 nmの吸光度を測定し、この吸光度を1九とす
る。
Buffer Sotrium benzoate 569 Caffeine anhydride 879 Sotrium acetate 94g Bridge-35709 Purified water 1e Diazo test armpit A Storichium chloride 11.7fl Sulfanilic acid 0.52g Concentrated hydrochloric acid 0.72 ml Purified water 100m (! Diazo test B Sodium nitrite 076g fi'j ''-L water 100ml! [■] Add 2.5 me of buffer solution to 4111 constant blood Wi 20 till of bilirubin amount,
Measure the absorbance at 580 nm and take this absorbance as 19.

次に、ジアソ゛5式楽(ジアン゛を式腋A:100me
にジアゾ試液f3 : l meを加えたもの) 0.
1 meを加えて1分間放置したのち、53 Q nm
の吸光度を測定し、その吸光度を1弓1とする。
Next, diaso 5-shiki music (giant armpit A: 100me
Diazo test solution f3: l me added to) 0.
After adding 1 me and leaving it for 1 minute, 53 Q nm
The absorbance is measured and the absorbance is defined as 1.

ビIJ 7レビン濃度既知の標1ff−血清について上
記と同様の操作を行い、ジアゾ試薬添加[)IJ後の5
30nrrlにおける吸光度SoおよびSlをめる。
Bi-IJ 7 Perform the same procedure as above for standard 1ff-serum with known Levin concentration, add diazo reagent [) 5 after IJ
Calculate the absorbance So and Sl at 30nrrl.

血清中の総ビリルビン帛は丁式からめられる。The total amount of bilirubin in the serum is expressed in the following manner.

(Cは標準血清の総ビリルビン値) ジアゾ試薬調製当日およびその後のfllll定により
得られた結果を第1表に示す。比較対照として、安定化
剤である塩化す1−リウムを含捷ない試薬を用いて同様
の4111定により経口斐化を調べたが、この場合は従
来言われているとおり調製当litのみの使用しかでき
なかった。
(C is the total bilirubin value of the standard serum) Table 1 shows the results obtained on the day of diazo reagent preparation and subsequent full determination. As a comparison, oral oxidation was investigated using the same 4111 test using a reagent that did not contain the stabilizer 1-lium chloride, but in this case, only the liter of preparation was used, as was conventionally said. That's all I could do.

第 1 表 (単位:mg/de> 実施例2 血清中の総ビリルビン量をベックマン・アメトラ−8自
動分析装置により自動測定した。使用した試液(緩匍液
、ジアゾ試腋AおよびB)は実施例1のそれと同じであ
る。
Table 1 (Unit: mg/de> Example 2 The total amount of bilirubin in serum was automatically measured using a Beckman Ametora-8 automatic analyzer. The test solutions used (slow solution, diazo test armpit A and B) were It is the same as that in Example 1.

この自動分析装置では、検体血清および標準血清のジア
ゾ試薬添加前後におけるそれぞれの吸光度lらo 、J
 、So 、 8 +が自動的に測定され、しかもその
ジアゾカップリングの反応時間は25秒(実施例1では
1分間)と短い。また、本装置では、既定の標準血清の
一般的な吸光度を記憶しており、測定される吸光度が、
記憶されている吸光度からある一定値以上はずれる場合
は、測定データに信頼性がないという理由で測定不可と
なる。
In this automatic analyzer, the absorbance of sample serum and standard serum before and after addition of the diazo reagent is determined by
, So , 8 + are automatically measured, and the reaction time of the diazo coupling is as short as 25 seconds (1 minute in Example 1). In addition, this device stores the general absorbance of predetermined standard serum, and the measured absorbance is
If the absorbance deviates from the stored absorbance by more than a certain value, the measurement data cannot be measured because it is unreliable.

上記ジアゾ試薬を用い、調製当日およびその後に総ビリ
ルビン量を自動的に測定した。検体血清は実施例1で使
用したものと同じである。7IllI定結果を第2表に
示す− 丑だ、上記自動分析装置による、総ビリルビン値を、従
来法〔用手法。ジアゾ試薬(安定化側合まず)は片時調
製〕による測定値と比較して相関をめ、第1図に示す結
果を得だ。但し、n=30゜3’=1.013X−0,
086、γ−0,9937、である。
Using the above diazo reagent, the total amount of bilirubin was automatically measured on the day of preparation and thereafter. The sample serum was the same as that used in Example 1. 7IllI determination results are shown in Table 2.The total bilirubin value was determined by the above automatic analyzer using the conventional method [manual method]. Diazo reagent (stabilized side does not combine) was compared with the measured value by one-time preparation] to find a correlation, and the results shown in Figure 1 were obtained. However, n=30°3'=1.013X-0,
086, γ-0,9937.

第 2 表 以」二のように、本発明のジアゾ試薬は安定性にすぐれ
ており、従来のジアゾ試薬が調製当日しか使用できない
のに対し、長時間の保存後の使用が可能である。しかも
その安定性は、従来のジアゾ試薬に単にハロゲン化アル
カリ金属塩を添加することによってもたらされるもので
、試薬の基本組成には何らの変更もないから、ビl) 
/レビン測定操作は従前と全く同様で、自動分析装置に
よる測定に容易に応用することができ、かつ従来と全く
同様の測定データを得ることができる。
As shown in Table 2 onwards, the diazo reagent of the present invention has excellent stability and can be used after long-term storage, whereas conventional diazo reagents can only be used on the day of preparation. Moreover, its stability is achieved by simply adding an alkali metal halide salt to the conventional diazo reagent, and there is no change in the basic composition of the reagent.
/Levin measurement operation is exactly the same as before, and can be easily applied to measurement by an automatic analyzer, and measurement data exactly the same as before can be obtained.

【図面の簡単な説明】[Brief explanation of drawings]

第1図は本発明のジアゾ試薬によるビIJ /レビン測
定値(自動分析装置による)と従来のジアゾ試薬による
ビl) /レビン測定値(用手法)との相関を示すグラ
フである。 代理人弁理士宮崎新八部 第1tm
FIG. 1 is a graph showing the correlation between the BiIJ/Levin measurement value using the diazo reagent of the present invention (by automatic analyzer) and the BiIJ/Levin measurement value using the conventional diazo reagent (manual method). Agent Patent Attorney Miyazaki Shinhachi Department 1st TM

Claims (2)

【特許請求の範囲】[Claims] (1)亜硝酸すトリウムとヌルファニルにより生成する
ジアゾニウム塩にハロゲン化アルカリ金属塩を共存させ
てなる安定性にすぐれたビリルビン測定用ジアゾ試薬。
(1) A highly stable diazo reagent for measuring bilirubin, which is made by coexisting an alkali metal halide salt with a diazonium salt produced from thorium nitrite and nurphanil.
(2) ハロゲン化アルカリ金属塩の添加量がモル数で
、ジアゾニウム塩の10〜20倍量である上記第(1)
項に記載のビIJ )レビン測定用ジアゾ試薬。
(2) Item (1) above, wherein the amount of the alkali metal halide salt added is 10 to 20 times the amount of the diazonium salt in terms of number of moles.
BiIJ) Diazo reagent for measuring Levin as described in Section 1.
JP3475984A 1984-02-24 1984-02-24 Diazo reagent for measuring bilirubin Granted JPS60178361A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP3475984A JPS60178361A (en) 1984-02-24 1984-02-24 Diazo reagent for measuring bilirubin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3475984A JPS60178361A (en) 1984-02-24 1984-02-24 Diazo reagent for measuring bilirubin

Publications (2)

Publication Number Publication Date
JPS60178361A true JPS60178361A (en) 1985-09-12
JPH0358468B2 JPH0358468B2 (en) 1991-09-05

Family

ID=12423240

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3475984A Granted JPS60178361A (en) 1984-02-24 1984-02-24 Diazo reagent for measuring bilirubin

Country Status (1)

Country Link
JP (1) JPS60178361A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996017251A1 (en) * 1994-12-02 1996-06-06 Nitto Boseki Co., Ltd. Method for determining bilirubin

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996017251A1 (en) * 1994-12-02 1996-06-06 Nitto Boseki Co., Ltd. Method for determining bilirubin
US5872009A (en) * 1994-12-02 1999-02-16 Nitto Boseki Co., Ltd. Method for measuring bilirubin

Also Published As

Publication number Publication date
JPH0358468B2 (en) 1991-09-05

Similar Documents

Publication Publication Date Title
US4303409A (en) Method, composition and test strip for colorimetric analysis of ascorbic acid
Kingsley et al. Microdetermination of arsenic and its application to biological material
Grady et al. Glucose determination by automatic chemical analysis
Goodwin Colorimetric measurement of serum bromide with a bromate-rosaniline method
US6066505A (en) Fluorescence polarization immunoassay
Byfield et al. Free thyroid hormone concentrations in subjects with various abnormalities of binding proteins: experience with Amerlex free‐T4 and free‐T3 assays
JP3569139B2 (en) Diazonium ion assay reagent and method of use
Boycks et al. Continuous-flow measurement of lactate in blood: a technique adapted for use in the emergency laboratory
JPS60178361A (en) Diazo reagent for measuring bilirubin
EP0510190B1 (en) Reagent and method for serum iron assay
CA1102226A (en) Urea assay and reagents therefor
Smith et al. The Kodak Ektachem 400 Analyzer evaluated for automated enzymic determination of plasma creatinine.
JPS61223651A (en) Method for quantitative determination of bilirubin
Moorehead et al. An automated micromethod for determination of serum glucose, with an improved o-toluidine reagent
CA2097471A1 (en) Fructosamine reagent and calibrator system
Holub et al. Automated direct method for measurement of serum cholesterol, with use of primary standards and a stable reagent
Pesce et al. Automated enzymatic micromethod for determination of uric acid in serum and urine with a centrifugal analyzer
JPH02122267A (en) Reagent kit for determining human hemoglobin and method for determining hemoglobin by using this kit
US4255412A (en) T3 Uptake test employing a precipitated nylon separating agent
Goodwin Direct estimation of serum iron and unsaturated iron binding capacity in a single aliquot
JPH07121235B2 (en) Indicator and reagent kit for measuring peroxide-decomposable substances
JP2001099826A (en) Method for developing color of complex, and reagent for developing color
Lehane et al. Colorimetric quantitation of albumin in microliter volumes of serum
JP2577431B2 (en) Method for measuring prostatic acid phosphatase
JPH0638757B2 (en) Peroxidase or H ▲ lower 2 ▼ O ▲ lower 2 ▼ measuring method